Trial Profile
A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2018
Price :
$35
*
At a glance
- Drugs Cocaine (Primary)
- Indications Anaesthesia
- Focus Pharmacokinetics
- 04 Sep 2018 Status changed from recruiting to completed.
- 21 May 2016 New trial record